Report cites FDA’s weaknesses over drugs, devices

WASHINGTON (Reuters) – The U.S. Food and Drug Administration, hampered by increasing globalization and a rise in complex products, may not be able to adequately protect the public’s health, the watchdog arm of Congress said in new findings released on Thursday.


Leave a Reply